EUVIMEDEUVIMED entdecken
Crossref

Nano Delivery of Plant Bioactive: Revolutionizing Neuroprotective Therapy for Neurodegenerative Diseases

Haranath Chinthaginjala, Maddileti Repollu, Kadapa Himabindu, Mounika Burusu, Macharla Manasa, Lekkalapudi Mamatha, Pathan Maahi Firdous Fathima, Maruru Ankitha, Sravani Yarra

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (20s)

DOI: 10.25258/ijddt.16.20s.22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Haranath Chinthaginjala und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease are progressive disorders characterized by neuronal degeneration and limited treatment options. A major challenge in their management is the blood–brain barrier (BBB), which restricts the delivery of therapeutic agents to the central nervous system. In this context, nanotechnology-based drug delivery systems have emerged as promising strategies to enhance brain targeting and therapeutic efficacy. This review evaluates the application of nano formulations for delivering plant-derived bioactive compounds in neurodegenerative disorders. Various nanocarriers, including liposomes, solid lipid nanoparticles, dendrimers, polymeric nanoparticles, and micelles, are discussed with respect to their physicochemical properties, BBB penetration ability, and pharmacokinetic advantages. Plant-derived phytoconstituents exhibit multiple neuroprotective mechanisms, such as antioxidant, anti-inflammatory, anti-apoptotic, and anti-protein aggregation effects; however, their clinical use is limited by poor solubility, low stability, and inadequate bioavailability. Nanoformulations significantly improve the delivery of these bioactives by enhancing solubility, enabling controlled and sustained release, and facilitating targeted transport across the BBB. Evidence from in vitro and in vivo studies demonstrates that nano-enabled phytochemicals effectively reduce oxidative stress, modulate neuroinflammation, prevent protein aggregation, and improve cognitive and motor functions. In conclusion, nano-based delivery of plant-derived compounds represents a promising therapeutic approach for neurodegenerative diseases. However, challenges related to large-scale production, reproducibility, long-term safety, and regulatory approval must be addressed to enable successful clinical translation.

Zitieren

APA

Chinthaginjala, H., Repollu, M., Himabindu, K., Burusu, M., Manasa, M., Mamatha, L., Fathima, P. M. F., Ankitha, M., & Yarra, S. (2026). Nano Delivery of Plant Bioactive: Revolutionizing Neuroprotective Therapy for Neurodegenerative Diseases. International Journal of Drug Delivery Technology, 16(20s). https://doi.org/10.25258/ijddt.16.20s.22

Vancouver

Chinthaginjala H, Repollu M, Himabindu K, Burusu M, Manasa M, Mamatha L, et al. Nano Delivery of Plant Bioactive: Revolutionizing Neuroprotective Therapy for Neurodegenerative Diseases. International Journal of Drug Delivery Technology. 2026;16(20s). doi:10.25258/ijddt.16.20s.22

BibTeX
@article{Chinthaginjala2026,
  author = {Chinthaginjala, Haranath and Repollu, Maddileti and Himabindu, Kadapa and Burusu, Mounika and Manasa, Macharla and Mamatha, Lekkalapudi and Fathima, Pathan Maahi Firdous and Ankitha, Maruru and Yarra, Sravani},
  title = {Nano Delivery of Plant Bioactive: Revolutionizing Neuroprotective Therapy for Neurodegenerative Diseases},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {20s},
  doi = {10.25258/ijddt.16.20s.22}
}
Kostenlos starten →